These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 25582316)
1. Distinct prognostic values of ALDH1 isoenzymes in breast cancer. Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316 [TBL] [Abstract][Full Text] [Related]
2. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer. You Q; Guo H; Xu D Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059 [TBL] [Abstract][Full Text] [Related]
4. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer. Ma YM; Zhao S Onco Targets Ther; 2016; 9():1981-8. PubMed ID: 27110126 [TBL] [Abstract][Full Text] [Related]
5. The prognostic roles of ALDH1 isoenzymes in gastric cancer. Li K; Guo X; Wang Z; Li X; Bu Y; Bai X; Zheng L; Huang Y Onco Targets Ther; 2016; 9():3405-14. PubMed ID: 27354812 [TBL] [Abstract][Full Text] [Related]
6. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data. Koh YW; Han JH; Haam S; Jung J J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946 [TBL] [Abstract][Full Text] [Related]
7. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Shima H; Kida K; Adachi S; Yamada A; Sugae S; Narui K; Miyagi Y; Nishi M; Ryo A; Murata S; Taniguchi H; Ichikawa Y; Ishikawa T; Endo I Breast Cancer Res Treat; 2018 Aug; 170(3):507-516. PubMed ID: 29693231 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas. Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962 [TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma. Yang CK; Wang XK; Liao XW; Han CY; Yu TD; Qin W; Zhu GZ; Su H; Yu L; Liu XG; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T PLoS One; 2017; 12(8):e0182208. PubMed ID: 28792511 [TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer. Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095 [TBL] [Abstract][Full Text] [Related]
11. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis. Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993 [TBL] [Abstract][Full Text] [Related]
12. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas. Madjd Z; Ramezani B; Molanae S; Asadi-Lari M Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492 [TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining. Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456 [TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma. Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277 [TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer. Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760 [TBL] [Abstract][Full Text] [Related]
16. The prognostic roles of circulating ALDH1 Tian S; Xing YN; Xia P Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380 [TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer. Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057 [TBL] [Abstract][Full Text] [Related]
18. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications. Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744 [TBL] [Abstract][Full Text] [Related]
20. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer. Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]